Live Chat

Risperdal Causes Male Breasts in Young Boys

//www.youtube.com/embed/M6qy0KVyjro?feature=player_detailpage

Risperdal, a common antipsychotic drug used for a variety of illnesses, has been seen to have some very negative and damaging side effects in young boys. The drug has been shown to increase the levels of prolactin in young boys thus causing them to develop male breasts, a condition known as Gynecomastia. This video describes the experience of Sam Wilson, a young boy who had developed this condition from his use of Risperdal. Like Sam, many young boys experience fear of humiliation and embarrassment because of the condition caused by this drug. In many cases these young boys are hurt psychologically more than they are helped.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects, and the following psychological trauma. This breast growth has been said to be the cause of many psychological symptoms which negatively impacts their quality of life. If you or a loved one have taken Risperdal and have experienced abnormal breast growth, we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim that is pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Categories
Drug Litigation